InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Tang
17 Jul 2026
10% owner
Buy indirect
50,945
$3.52
$179.33K
Kevin Tang
16 Jul 2026
10% owner
Buy indirect
116,671
$3.56
$415.35K
Kevin Tang
15 Jul 2026
10% owner
Buy indirect
107,377
$3.56
$382.26K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
75,952
$3.58
$271.91K
Kevin Tang
14 Jul 2026
10% owner
Buy indirect
53,651
$3.56
$191.00K
Kevin Tang
13 Jul 2026
10% owner
Buy indirect
12,966
$3.54
$45.90K
Alan Ezekowitz
26 Jun 2026
Director
Sell
18,000
$3.65
$65.61K
Robert J Gould
2 Feb 2026
Director
Sell
15,000
$10.72
$160.86K
Robert J Gould
2 Jan 2026
Director
Sell
15,000
$11.87
$178.09K
Curtis Gale Oltmans
15 Dec 2025
Chief Legal Officer
Sell
3,452
$12.92
$44.60K
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
91,722
$14.98
$1.37M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
2,706,397
$14.28
$38.65M
Ra Capital Management, L.p.
8 Dec 2025
10% owner
Sell indirect
1,377,020
$13.33
$18.36M
Robert J Gould
19 Nov 2025
Director
Sell
15,000
$11.03
$165.50K

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 0
History held since 18 Jul 2019